2. Academic Validation
  3. Novel Tricyclic Compounds as TLR7 Agonists for Treating Cancer

Novel Tricyclic Compounds as TLR7 Agonists for Treating Cancer

  • ACS Med Chem Lett. 2025 Oct 28;16(11):2208-2209. doi: 10.1021/acsmedchemlett.5c00635.
Ram W Sabnis 1
Affiliations

Affiliation

  • 1 Arclin USA LLC, 1150 Sanctuary Parkway, Suite 100, Alpharetta, Georgia 30009, United States.
PMID: 41256979 DOI: 10.1021/acsmedchemlett.5c00635
Abstract

Provided herein are novel tricyclic compounds as TLR7 agonists, pharmaceutical compositions, use of such compounds in treating Cancer, and processes for preparing such compounds.

Figures
Products